Skip to comments.

Posted on 10/01/2001 7:47:12 PM PDT by Brian Kopp DPM

Virtual Naval Hospital: Treatment of Biological Warfare Agent Casualties: Table of Contents

Treatment of Biological Warfare Agent Casualties

Headquarters Departments of
The Army, The Navy and The Air Force
and Commandant, Marine Corps

Washington, DC
17 July 2000

Field Manual No. 8-284
NAVMED P-5042
Air Force Manual (Interface) No. 44-156
Marine Corps MCRP 4-11.1C

Table of Contents

Preface

Chapter 1 - Introduction

1-1.   The Threat of Biological Warfare Agents Against United States Forces and Civilian Populations

1-2.   Modes of Delivery

1-3.   Employment of Biological Warfare Agents

1-4.   Classification of Biological Warfare Agents

1-5.   Portals of Entry

1-6.   Environmental Detection

1-7.   Diagnosis

1-8.   Specimen Collection

1-9.   Specimen Labeling

1-10.   Specimen Handling and Shipment

1-11.   Chain of Custody Responsibilities

1-12.   Identification Methods for Biological Warfare Agents

1-13.   Therapy

1-14.   Case Reporting and Epidemiological Assessment

1-15.   Prevention

1-16.   Protective Equipment

1-17.   First Aid

1-18.   Protective Measures and Handling of Casualties

1-19.   Patient Decontamination

1-20.   Infection Control

1-21.   Medical Evacuation

1-22.   Aeromedical Isolation Team

Chapter 2 - Bacterial Agents

Section I - Introduction

2-1.   General

Section II - Anthrax

2-2.   General

2-3.   Biological Warfare Agent Delivery

2-4.   Environmental Detection

2-5.   Prevention

2-6.   Biological Warfare Clinical Presentation

2-7.   Diagnosis

2-8.   Treatment

2-9.   Control of Patients, Contacts, and Treatment Areas

2-10.   Medical Evacuation

Section III - Brucellosis

2-11.   General

2-12.   Biological Warfare Agent Delivery

2-13.   Environmental Detection

2-14.   Prevention

2-15.   Biological Warfare Clinical Presentation

2-16.   Diagnosis

2-17.   Treatment

2-18.   Control of Patients, Contacts, and Treatment Areas

2-19.   Medical Evacuation

Section IV - Melioidosis

2-20.   General

2-21.   Biological Warfare Agent Delivery

2-22.   Environmental Detection

2-23.   Prevention

2-24.   Biological Warfare Clinical Presentation

2-25.   Diagnosis

2-26.   Treatment

2-27.   Control of Patients, Contacts, and Treatment Areas

2-28.   Medical Evacuation

Section V - Glanders

2-29.   General

2-30.   Biological Warfare Agent Delivery

2-31.   Environmental Detection

2-32.   Prevention

2-33.   Biological Warfare Clinical Presentation

2-34.   Diagnosis

2-35.   Treatment

2-36.   Control of Patients, Contacts, and Treatment Areas

2-37.   Medical Evacuation

Section VI - Plague

2-38.   General

2-39.   Biological Warfare Agent Delivery

2-40.   Environmental Detection

2-41.   Prevention

2-42.   Biological Warfare Clinical Presentation

2-43.   Diagnosis

2-44.   Treatment

2-45.   Control of Patients, Contacts, and Treatment Areas

2-46.   Medical Evacuation

Section VII - Q Fever

2-47.   General

2-48.   Biological Warfare Agent Delivery

2-49.   Environmental Detection

2-50.   Prevention

2-51.   Biological Warfare Clinical Presentation

2-52.   Diagnosis

2-53.   Decontamination

2-54.   Treatment

2-55.   Control of Patients, Contacts, and Treatment Areas

2-56.   Medical Evacuation

Section VIII - Tularemia

2-57.   General

2-58.   Biological Warfare Agent Delivery

2-59.   Environmental Detection

2-60.   Prevention

2-61.   Biological Warfare Clinical Presentation

2-62.   Diagnosis

2-63.   Treatment

2-64.   Control of Patients, Contacts, and Treatment Areas

2-65.   Medical Evacuation

Chapter 3 - Viral Agents

Section I - Introduction

3-1.   General

Section II - Smallpox

3-2.   General

3-3.   Biological Warfare Agent Delivery

3-4.   Environmental Detection

3-5.   Prevention

3-6.   Biological Warfare Clinical Presentation

3-7.   Diagnosis

3-8.   Treatment

3-9.   Control of Patients, Contacts, and Treatment Areas

3-10.   Medical Evacuation

Section III - Venezuelan Equine Encephalitis

3-11.   General

3-12.   Biological Warfare Agent Delivery

3-13.   Environmental Detection

3-14.   Prevention

3-15.   Biological Warfare Clinical Presentation

3-16.   Diagnosis

3-17.   Treatment

3-18.   Control of Patients, Contacts, and Treatment Areas

3-19.   Medical Evacuation

Section IV - Viral Hemorrhagic Fevers

3-20.   General

3-21.   Biological Warfare Agent Delivery

3-22.   Environmental Detection

3-23.   Prevention

3-24.   Biological Warfare Clinical Presentation

3-25.   Diagnosis

3-26.   Treatment

3-27.   Control of Patients, Contacts, and Treatment Areas

3-28.   Medical Evacuation

Chapter 4 - Toxins

Section I - Introduction

4-1.   General

Section II - Clostridium Botulinum Toxin

4-2.   General

4-3.   Biological Warfare Agent Delivery

4-4.   Environmental Detection

4-5.   Prevention

4-6.   Biological Warfare Clinical Presentation

4-7.   Diagnosis

4-8.   Treatment

4-9.   Control of Patients, Contacts, and Treatment Areas

4-10.   Medical Evacuation

Section III - Clostridium Perfringens Toxin

4-11.   General

4-12.   Biological Warfare Agent Delivery

4-13.   Environmental Detection

4-14.   Prevention

4-15.   Biological Warfare Clinical Presentation

4-16.   Diagnosis

4-17.   Treatment

4-18.   Control of Patients, Contacts, and Treatment Areas

4-19.   Medical Evacuation

Section IV - Ricin

4-20.   General

4-21.   Biological Warfare Agent Delivery

4-22.   Environmental Detection

4-23.   Prevention

4-24.   Biological Warfare Clinical Presentation

4-25.   Diagnosis

4-26.   Treatment

4-27.   Control of Patients, Contacts, and Treatment Areas

4-28.   Medical Evacuation

Section V - Saxitoxin

4-29.   General

4-30.   Biological Warfare Agent Delivery

4-31.   Environmental Detection

4-32.   Prevention

4-33.   Biological Warfare Clinical Presentation

4-34.   Diagnosis

4-35.   Treatment

4-36.   Control of Patients, Contacts, and Treatment Areas

4-37.   Medical Evacuation

Section VI - Staphylococcal Enterotoxin B

4-38.   General

4-39.   Biological Warfare Agent Delivery

4-40.   Environmental Detection

4-41.   Prevention

4-42.   Biological Warfare Clinical Presentation

4-43.   Diagnosis

4-44.   Treatment

4-45.   Control of Patients, Contacts, and Treatment Areas

4-46.   Medical Evacuation

Section VII - Trichothecene Mycotoxins

4-47.   General

4-48.   Biological Warfare Agent Delivery

4-49.   Environmental Detection

4-50.   Prevention

4-51.   Biological Warfare Clinical Presentation

4-52.   Diagnosis

4-53.   Treatment

4-54.   Control of Patients, Contacts, and Treatment Areas

4-55.   Medical Evacuation

Appendix A - Recognition of a Biological Warfare Agent Casualty

A-1.   General

A-2.   Types of Casualties

A-3.   Recognize Biological Casualties

Appendix B - Medical Management and Treatment in Biological Warfare Operations

Section I - US Army Medical Treatment Facilities

B-1.   General

B-2.   Objectives of Health Service Support in Biological Warfare Operations

B-3.   Planning for the Management and Treatment of Biologically Contaminated Casualties

B-4.   Emergency Medical Treatment of Biologically Contaminated Casualties

B-5.   Patient Decontamination Methods

B-6.   Logistics

B-7.   Training

B-8.   Casualty Evacuation

Section II - US Air Force Medical Treatment Facilities

B-9.   General

B-10.   Detection of Biological Agents

B-11.   Identification

B-12.   Decontamination

Section III - Navy Medical Treatment Facilities

B-13.   General

Glossary

Section I - Abbreviations and Acronyms

Section II - Definitions

References

Index

All contents copyright © 1997-2001 The University of Iowa. All rights reserved.

URL: http://www.vnh.org/

http://www.vnh.org/FM8284/index.html
Modified: Tue Jun 19 15:28:29 2001
Displayed: Mon Oct 1 21:38:08 2001

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.